The symptomatology of cerebrospinal fluid HIV RNA escape: a large case-series
- 15 June 2021
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 35 (14), 2341-2346
- https://doi.org/10.1097/qad.0000000000002992
Abstract
Objective: To characterise the clinical, laboratory and radiological characteristics of persons with HIV (PWH) presenting with cerebrospinal fluid (CSF) HIV RNA escape. Design: Retrospective case review of PWH presenting with symptomatic CSF HIV RNA escape at seven tertiary HIV clinical sites in UK and Italy Method: PWH with symptomatic CSF HIV RNA escape episodes were identified and data obtained from medical records. CSF HIV RNA escape was defined as quantifiable CSF HIV RNA in unquantifiable plasma HIV RNA or CSF HIV RNA greater than plasma HIV RNA in cases where plasma HIV RNA was quantifiable. The onset of clinical symptoms was classified as acute (6 months) and differences in presentation in those with CSF HIV RNA below and above 1000 copies/mL determined. Results: We identified 106 PWH with CSF HIV RNA escape (65 male); 68 (64%) PWH had acute presentations and 38 (36%) had chronic presentations. Cognitive decline (n = 54, 50.9%), confusion (n = 20, 18.9%) and headache (n = 28, 26.4%) were the most common presentations, with cognitive decline being more common in PWH who presented chronically compared with PWH who presented acutely (73.7% vs 35.3%, p = 0.0002). Sixty PWH had CSF HIV RNA ≥1000 copies/mL and presented more frequently with confusion (n = 15/60, 25.0%) compared to PWH with CSF HIV RNA <1000 copies/mL at presentation (n = 5/46, 10.9%; p = 0.03). Conclusion: Cognitive decline, confusion and headache are the most frequent presenting symptoms of CSF HIV RNA escape and their relative frequency varied according to symptom onset and CSF HIV RNA concentration.Keywords
This publication has 14 references indexed in Scilit:
- Recurrent cerebrospinal fluid escape in an HIV-1-infected patient receiving antiretroviral therapyAIDS, 2016
- Cerebrospinal Fluid HIV Escape from Antiretroviral TherapyCurrent HIV/AIDS Reports, 2015
- Short Communication: Focal Encephalitis Related to Viral Escape and Resistance Emergence in Cerebrospinal Fluid in a Patient on Lopinavir/Ritonavir Monotherapy with Plasma HIV-1 RNA SuppressionAIDS Research and Human Retroviruses, 2014
- Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral loadAIDS, 2012
- Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General PopulationClinical Infectious Diseases, 2011
- Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral TherapyClinical Infectious Diseases, 2010
- Low atazanavir concentrations in cerebrospinal fluidAIDS, 2009
- Cerebrospinal Fluid Viral Loads Reach Less than 2 Copies/ML in HIV-1-Infected Patients with Effective Antiretroviral TherapyAntiviral Therapy, 2005
- Concentrations of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in Cerebrospinal Fluid after Antiretroviral Treatment Initiated during Primary HIV-1 InfectionClinical Infectious Diseases, 2001
- Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infectionAIDS, 1999